Rare Disease Patient Advocacy Groups: Hiring Freeze Puts Cures Law, Orphan Drug Development At Risk

February 24, 2017 at 7:25 PM
The federal hiring freeze puts at risk implementation of the 21st Century Cures and orphan drug laws, more than 200 individuals and patient advocacy organizations wrote in a letter to President Donald Trump. The letter says much progress has been made developing treatments for the 30 million Americans who have a rare disease, but agencies must have the ability to hire experts to keep pace with innovation. “In order to ensure America’s continued global leadership in health innovation and biomedical...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.